Effects of low dose oxymatrine on mouse lymphocyte proliferation stimulated by Con A

Abstract

Objective To investigate the effects of low dose Oxymatrine (OMT) on mouse lymphocyte proliferation stimulated by Con A making use of fluorescence dyestuff (CFDA-SE). Methods CFDA-SE staining and flow cytometry were used to detect the fluorescence intensity of lymphocytes after stimulated by polyclonal stimulators Con A and OMT. Then, related software was used to analyze the effects of OMT on mouse lymphocyte proliferation. Results After cultured for 48 h, CFSE fluorescence could be detected by cytometer, filial generation peaks did not appear in control group, which indicated that lymphocytes did not proliferate. Three peaks were obviously detected in Con A group which indicated that Lymphocytes divided after 48 h stimulated by Con A compared with the halving of the fluorescence intensity of control group. In groups with Con A and OMT treated. Primary generation peaks are all lower while filial generation peaks are significantly higher than groups with Con A treated only. This indicated OMT obviously promote lymphocyte proliferation. After cultured for 72 h, the fluorescence intensity changes between all groups are consistent with those of cultured for 48 h. Analyzed with CELLQuest software, it is shown that OMT could promote lymphocyte proliferation in 16, 8, 4 and 2 μg/mL respectively. Conclusions 1)CFDA-SE dyeing and flow cytometer were both reliable tools to analyse lymphocyte proliferation; 2) lower dosage of OMT could promote the proliferation of lymphocyte as a immunopotentiator.

Keywords

CFDA-SE / OMT / lymphocyte / proliferation

References

[1] MaJun-jiang, ChenXue-rong, SiLa-pu, et al.. Restrain of oxymatrine on type I–IV allergic reactions [J]. Journal of Beijing Medical University, 1991, 23(6): 445-445

[2] ZhaoJing-xian, ZengYao-ying. Application of alive dyestuff CFDA-SE in the research of lymphocyte proliferation[J]. Journal of Cellular and Molecular Immunology, 2003, 19(2): 109-111

[3] FulcherD, WongS. Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic Laboratory[J]. Immunology cell Biol, 1999, 77(6): 559-564

[4] LiChang-qing. The research of oxymatrine in treating liver diseases[J]. Journal of Tropic Medicine, 2003, 3(2): 243-245

[5] WangXiao, DongXiang-yu, ZhuChuan-an. Effects of oxymatrine on peripheral T lymphocyte subsets of chronic HBV hepatitis patient[J]. Clinical Focus, 2001, 16(18): 841-841

[6] LiZheng-rong. The progress of oxymatrine in pharmacology and cinical research[J]. West China Journal of Pharmaceutical Sciences, 2003, 18(6): 435-437

[7] ShenZhi-hong, WuYi-xuan, MaoWei-han. Injection of oxymatrine treat all kinds of eczema[J]. Chin J New Drugs Clin Rem, 2000, 19(6): 473-474

[8] HuYa-ni, WangSi-wang, XieYan-hua. The research of oxymatrine on antitumor effects[J]. Journal of Liaoning College of Traditional Chinese, 2003, 5(1): 3-5

[9] KongQing-zhi, HuangTao, HuangDong-sheng, et al.. Experimental study on inhibiting effect of oxymatrine on mice's angiogenesis from S180 sarcoma [J]. China Pharmacist, 2003, 6(12): 769-771

[10] GaoHong-quan, WangYing, YangChung-zhuang. Studies on oxymatrine induces apoptosis in ovarian cancer cell lines HO8910[J]. Acta Chinese Medicine and Pharmacology, 2004, 32(2): 52-55